231 related articles for article (PubMed ID: 12449158)
1. Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma.
Kanniess F; Richter K; Janicki S; Schleiss MB; Jörres RA; Magnussen H
Eur Respir J; 2002 Nov; 20(5):1080-7. PubMed ID: 12449158
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
[TBL] [Abstract][Full Text] [Related]
3. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
Laviolette M; Malmstrom K; Lu S; Chervinsky P; Pujet JC; Peszek I; Zhang J; Reiss TF
Am J Respir Crit Care Med; 1999 Dec; 160(6):1862-8. PubMed ID: 10588598
[TBL] [Abstract][Full Text] [Related]
4. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
[TBL] [Abstract][Full Text] [Related]
5. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children.
Ghiro L; Zanconato S; Rampon O; Piovan V; Pasquale MF; Baraldi E
Eur Respir J; 2002 Sep; 20(3):630-4. PubMed ID: 12358339
[TBL] [Abstract][Full Text] [Related]
6. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
7. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation.
Fahy JV; Boushey HA
Eur Respir J; 1998 Jun; 11(6):1240-7. PubMed ID: 9657561
[TBL] [Abstract][Full Text] [Related]
8. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
Williams B; Noonan G; Reiss TF; Knorr B; Guerra J; White R; Matz J
Clin Exp Allergy; 2001 Jun; 31(6):845-54. PubMed ID: 11422148
[TBL] [Abstract][Full Text] [Related]
9. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
Grosclaude M; Cerruti JL; Delannay B; Hérent M; Spilthooren F; Desfougères JL
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
[TBL] [Abstract][Full Text] [Related]
10. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
O'Sullivan S; Akveld M; Burke CM; Poulter LW
Am J Respir Crit Care Med; 2003 Mar; 167(5):745-50. PubMed ID: 12480610
[TBL] [Abstract][Full Text] [Related]
11. Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma.
Kanniess F; Richter K; Böhme S; Jörres RA; Magnussen H
Eur Respir J; 2002 Oct; 20(4):853-8. PubMed ID: 12412675
[TBL] [Abstract][Full Text] [Related]
12. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
Green RH; Brightling CE; McKenna S; Hargadon B; Neale N; Parker D; Ruse C; Hall IP; Pavord ID
Eur Respir J; 2006 Jun; 27(6):1144-51. PubMed ID: 16455831
[TBL] [Abstract][Full Text] [Related]
13. Effect of fluticasone 250 microg/salmeterol 50 microg and montelukast on exhaled nitric oxide in asthmatic patients.
Gelb AF; Taylor CF; Shinar CM; Gutierrez CA; Zamel N
Can Respir J; 2008; 15(4):193-8. PubMed ID: 18551200
[TBL] [Abstract][Full Text] [Related]
14. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship.
Jones SL; Herbison P; Cowan JO; Flannery EM; Hancox RJ; McLachlan CR; Taylor DR
Eur Respir J; 2002 Sep; 20(3):601-8. PubMed ID: 12358335
[TBL] [Abstract][Full Text] [Related]
15. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
Dempsey OJ; Wilson AM; Sims EJ; Mistry C; Lipworth BJ
Chest; 2000 Apr; 117(4):950-3. PubMed ID: 10767223
[TBL] [Abstract][Full Text] [Related]
16. Airway mechanics after withdrawal of a leukotriene receptor antagonist in children with mild persistent asthma: Double-blind, randomized, cross-over study.
Kim JH; Lee S; Shin YH; Ha EK; Lee SW; Kim MA; Yoon JW; Baek HS; Choi SH; Han MY
Pediatr Pulmonol; 2020 Dec; 55(12):3279-3286. PubMed ID: 32965787
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.
Ciółkowski J; Mazurek H; Hydzik P; Stasiowska B
Pulm Pharmacol Ther; 2016 Aug; 39():7-13. PubMed ID: 27234706
[TBL] [Abstract][Full Text] [Related]
18. Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses.
Pizzichini MM; Kidney JC; Wong BJ; Morris MM; Efthimiadis A; Dolovich J; Hargreave FE
Eur Respir J; 1996 Mar; 9(3):449-55. PubMed ID: 8730003
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral montelukast on airway function in acute asthma.
Cýllý A; Kara A; Ozdemir T; Oğüş C; Gülkesen KH
Respir Med; 2003 May; 97(5):533-6. PubMed ID: 12735671
[TBL] [Abstract][Full Text] [Related]
20. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.
Tohda Y; Fujimura M; Taniguchi H; Takagi K; Igarashi T; Yasuhara H; Takahashi K; Nakajima S
Clin Exp Allergy; 2002 Aug; 32(8):1180-6. PubMed ID: 12190656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
